These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26019986)

  • 1. Medicare reimbursement to ophthalmologists: a comparison of Hawai'i to other states.
    Juarez DT; Guimaraes A; Seto B; Davis JW
    Hawaii J Med Public Health; 2015 May; 74(5):169-73. PubMed ID: 26019986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013.
    Han E; Baisiwala S; Jain A; Bundorf MK; Pershing S
    Am J Ophthalmol; 2017 Oct; 182():133-140. PubMed ID: 28784553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Primary Care Physician Reimbursement Rates in the United States.
    Riley N; Withy K; Rogers K; DuBose-Morris R; Kurozawa T
    Hawaii J Med Public Health; 2017 Mar; 76(3 Suppl 1):24-27. PubMed ID: 28435755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Clinical Activity and Medicare Payments for Female vs Male Ophthalmologists.
    Reddy AK; Bounds GW; Bakri SJ; Gordon LK; Smith JR; Haller JA; Berrocal AM; Thorne JE
    JAMA Ophthalmol; 2017 Mar; 135(3):205-213. PubMed ID: 28114631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists.
    Dickson SR; James KE
    JAMA Health Forum; 2023 Sep; 4(9):e232951. PubMed ID: 37682553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Payment Transformation in Hawai'i Based on Physician Perspective.
    Young K; Huynh J; Joo K; Withy K
    Hawaii J Health Soc Welf; 2022 Jul; 81(7):193-197. PubMed ID: 35821669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Specific Trends in Ophthalmologist Medicare Collections.
    Ahmad S; Ramulu P; Akpek E; Deobhakta A; Klawe J
    Am J Ophthalmol; 2020 Jun; 214():32-39. PubMed ID: 31926887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming and improving health care through meaningful use of health information technology.
    Chin BJ; Sakuda CM
    Hawaii J Med Public Health; 2012 Apr; 71(4 Suppl 1):50-5. PubMed ID: 22737643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision care policy, ophthalmological practices and the Medicare program.
    Soroka M; Rosenthal J
    J Am Optom Assoc; 1983 Jun; 54(6):565-71. PubMed ID: 6348137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.
    Taylor SC; Huecker JB; Gordon MO; Vollman DE; Apte RS
    JAMA Ophthalmol; 2016 Aug; 134(8):897-903. PubMed ID: 27356110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference in rural and urban Medicare prescription pattern for Parkinson's disease in Hawai'i.
    Bruno MK; Watanabe G; Gao F; Seto T; Nakagawa K; Trinacty C; Brown S; Taira DA
    Clin Park Relat Disord; 2022; 6():100144. PubMed ID: 35521293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in Medicare Reimbursements among Ophthalmologists Persist across Time.
    Halawa OA; Sekimitsu S; Boland MV; Zebardast N
    Ophthalmology; 2022 Sep; 129(9):1056-1063. PubMed ID: 35588946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Anti-VEGF Injection Medicare Part B Claims among Male and Female Ophthalmologists from 2012-2016.
    Pradeep T; Melachuri S; Arun S; Ravipati A; Wang S; Zhang M; Errera MH; Fu R
    Semin Ophthalmol; 2021 Nov; 36(8):628-632. PubMed ID: 33678125
    [No Abstract]   [Full Text] [Related]  

  • 14. The Impact of the Medicare Access and CHIP Reauthorization Act on the Field of Ophthalmology.
    Kinker B; Dobesh K; Nassiri N; Juzych MS; Wilson MR
    Am J Ophthalmol; 2017 Jul; 179():1-9. PubMed ID: 28414044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Hawai'i Ophthalmologists' Recommendations to Patients for Prevention of Age-Related Macular Degeneration.
    Card KR; Golez J; Ing MR
    Hawaii J Health Soc Welf; 2022 Feb; 81(2):34-37. PubMed ID: 35156054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of charges by optometrists and ophthalmologists under the Medicare program.
    Soroka M
    J Am Optom Assoc; 1991 May; 62(5):372-6. PubMed ID: 1813532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State variation in Medicaid and Medicare reimbursements in musculoskeletal radiology.
    Santiago CC; Santiago DC; Sebro R
    Clin Imaging; 2020 Oct; 66():67-72. PubMed ID: 32454392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in Medicare Utilization and Reimbursement Rates in Ophthalmic Plastic and Reconstructive Surgery: 2010-2019.
    Gong JH; Khurana A; Eltorai AEM; Wagner LH
    Ann Plast Surg; 2022 Jan; 88(1):93-98. PubMed ID: 34176907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Medicare Optometry Parity Amendment: predicted and actual payments to optometrists and ophthalmologists.
    Soroka M; Barresi BJ
    J Am Optom Assoc; 1991 Sep; 62(9):699-703. PubMed ID: 1815004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.